CD4 and Cirrhosis: After the exclusion of people with comorbidities or conditions potentially affecting the immune recovery (i.e., cirrhosis, autoimmune diseases and/or malignancies, previous CVD events, N = 59), we found that the CD4/CD8 ratios showed similar increases to those of the whole study population.